- Home
- PBYI vs LANV Comparison
PBYI vs LANV Comparison
Compare PBYI & LANV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- LANV
- Stock Information
- Founded
- PBYI 2010
- LANV 2015
- Country
- PBYI United States
- LANV China
- Employees
- PBYI N/A
- LANV N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- LANV Blank Checks
- Sector
- PBYI Health Care
- LANV Finance
- Exchange
- PBYI Nasdaq
- LANV Nasdaq
- Market Cap
- PBYI 176.1M
- LANV 173.2M
- IPO Year
- PBYI N/A
- LANV N/A
- Fundamental
- Price
- PBYI $2.32
- LANV $1.77
- Analyst Decision
- PBYI Strong Buy
- LANV
- Analyst Count
- PBYI 1
- LANV 0
- Target Price
- PBYI $7.00
- LANV N/A
- AVG Volume (30 Days)
- PBYI 393.6K
- LANV 80.6K
- Earning Date
- PBYI 10-31-2024
- LANV 08-26-2024
- Dividend Yield
- PBYI N/A
- LANV N/A
- EPS Growth
- PBYI N/A
- LANV N/A
- EPS
- PBYI 0.18
- LANV N/A
- Revenue
- PBYI $219,143,000.00
- LANV $409,961,427.00
- Revenue This Year
- PBYI N/A
- LANV N/A
- Revenue Next Year
- PBYI N/A
- LANV $76.77
- P/E Ratio
- PBYI $12.75
- LANV N/A
- Revenue Growth
- PBYI N/A
- LANV N/A
- 52 Week Low
- PBYI $2.13
- LANV $0.91
- 52 Week High
- PBYI $7.73
- LANV $4.70
- Technical
- Relative Strength Index (RSI)
- PBYI 34.73
- LANV 58.24
- Support Level
- PBYI $2.23
- LANV $1.66
- Resistance Level
- PBYI $2.56
- LANV $1.85
- Average True Range (ATR)
- PBYI 0.17
- LANV 0.19
- MACD
- PBYI -0.01
- LANV 0.02
- Stochastic Oscillator
- PBYI 14.06
- LANV 53.33
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About LANV Lanvin Group Holdings Limited
Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the Wolford segment.